Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Prophylaxis for Hypertensive Disorders of Pregnancy
NCT02920593Phase 4Unknown
- Sponsor
- Stony Brook University
- Start
- Oct 2016
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vitamin d in hypertensive disorders of pregnancy (HDP), sponsored by Stony Brook University. Primary endpoint: Incidence of hypertensive disorders of pregnancy at 1.5 years. Status: unknown.
02
Drugs
vitamin d
03
Conditions
hypertensive disorders of pregnancy (HDP)
Beyond the preview
Go deeper on NCT02920593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920593.